ArticleInternational journal of general medicine2025
Expression Significance of Serum Circular RNA CDYL and Circular RNA ROBO2 in Patients with Acute Myocardial Infarction and the Value of Their Combined Prediction for Major Adverse Cardiovascular Events.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the expression changes of circular RNAs CDYL and ROBO2 in the serum of patients with acute myocardial infarction (AMI), explore their potential association with the occurrence of major adverse cardiovascular events (MACE), and evaluate the clinical value of their combined detection in predicting MACE after percutaneous coronary intervention (PCI). Methods: A retrospective cohort study was conducted on 119 AMI patients who underwent PCI (observation group) between February 2023 and February 2024. Based on post-PCI MACE occurrence, patients were categorized into Group A (with MACE, n=47) and Group B (without MACE, n=72). Additionally, 100 healthy volunteers were enrolled as controls. Serum levels of circRNA CDYL and circRNA ROBO2 were measured by quantitative real-time polymerase chain reaction (qRT-PCR). Pearson correlation analysis assessed their relationship. Multivariate logistic regression identified factors independently associated with MACE. Receiver operating characteristic (ROC) curves evaluated the predictive performance of each circRNA and their combination for MACE. Results: Serum circRNA CDYL was significantly downregulated in AMI patients, while circRNA ROBO2 was upregulated, showing a strong negative correlation (r = -0.659, P<0.001). The MACE group exhibited lower circRNA CDYL and higher circRNA ROBO2 levels than the non-MACE group (P<0.05). Multivariate analysis identified high circRNA ROBO2 as an independent risk factor for MACE, while high circRNA CDYL was a protective factor. The combined detection of both circRNAs predicted MACE with an area under the curve (AUC) of 0.901, significantly outperforming either marker alone (sensitivity=89.74%, specificity=80.51%). Conclusion: Serum circRNA CDYL and ROBO2 are significantly associated with MACE risk in AMI patients after PCI. Their combined detection shows promising predictive value. However, these findings from a retrospective study are preliminary and require validation in prospective cohorts and further mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.